Infectious Diseases (42)

FDA Approves New Antibacterial Drug for Serious Lung Disease Under Novel Pathway

On September 28, 2018, the FDA announced approval of Arikayce (amikacin liposome inhalation suspension) to treat lung disease caused by Mycobacterium avium complex (MAC) in a limited population of patients with the disease who do not respond to conventional treatment. The drug is the first to be approved under the...